Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

V2005

Sigma-Aldrich

[deamino-Pen1, Val4, D-Arg8]-Vasopressin

≥97% (HPLC)

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C48H69N13O11S2
CAS Number:
64158-84-5
Molecular Weight:
1068.27
MDL number:
MFCD00076746
UNSPSC Code:
12352200
PubChem Substance ID:
24900724

Assay

≥97% (HPLC)

storage temp.

−20°C

SMILES string

CC(C)C1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc3ccc(O)cc3)NC(=O)CC(C)(C)SSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N4CCCC4C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O

Amino Acid Sequence

3-Mercapto-3-methylbutyryl-Tyr-Phe-Val-Asn-Cys-Pro-D-Arg-Gly-NH2 [Disulfide Bridge: 1-6]

Biochem/physiol Actions

Agonist at the V2 vasopressin receptor (antidiuretic) and antagonist at the V1 receptor (vasopressor).

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H332

Hazard Classifications

Acute Tox. 4 Inhalation

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
055K1530
111H01504
111H01503
087H0705
087H07051

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

G Mazzocchi et al.
Neuropeptides, 24(2), 105-108 (1993-02-01)
Acute and chronic systemic administrations of neurotensin (NT) and arginine-vasopressin (AVP) significantly increases plasma aldosterone concentration (PAC) in rats. Deamino-Pen1, Val4, D-Arg8-vasopressin (AVP-A), a potent AVP antagonist, completely reversed both acute and chronic aldosterone secretagogue actions of NT and AVP.
Wei Wei et al.
The Annals of thoracic surgery, 73(2), 516-522 (2002-02-16)
Arginine vasopressin (AVP) has recently been demonstrated as an alternative in the treatment of severe refractory vasodilatation in coronary artery bypass grafting. However, AVP may be a spasmogen for graft spasm. We compared the in vitro antispastic effect among calcium-channel
J R McNeill
Canadian journal of physiology and pharmacology, 61(7), 770-773 (1983-07-01)
[1-deaminopenicillamine, 4-valine, 8-D-arginine]Vasopressin (DPVDAVP), a specific antagonist of the pressor activity of vasopressin, and teprotide, a converting enzyme inhibitor, were infused intravenously in conscious, fasted (24-30 h) but not water-deprived cats which had been implanted previously with flow probes on
G Mazzocchi et al.
The Journal of steroid biochemistry and molecular biology, 45(4), 251-256 (1993-04-01)
A 7-day subcutaneous infusion with the AVP antagonist [Deamino-Pen1, Val4, D-Arg8]-vasopressin (AVP-A; 3 nmol.kg-1 x min-1) significantly lowered plasma aldosterone concentration in rats, without affecting the plasma levels of ACTH and corticosterone. Prolonged AVP-A treatment caused a marked atrophy of
L Bueno et al.
The American journal of physiology, 262(3 Pt 1), G427-G431 (1992-03-01)
The effects of emotional stress (ES) corresponding to conditioned fear on colonic motility and its antagonism by [deamino-Pen1, Val4, D-Arg8]vasopressin, a vasopressin antagonist, were investigated by electromyography in conscious fasted rats fitted with chronically implanted electrodes. A 117% increase (19.6
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service